Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
122,470,452
-
Total 13F shares
-
52,818,611
-
Share change
-
-202,826
-
Total reported value
-
$1,008,878,346
-
Put/Call ratio
-
33%
-
Price per share
-
$19.10
-
Number of holders
-
181
-
Value change
-
-$1,266,933
-
Number of buys
-
80
-
Number of sells
-
93
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q4 2023
As of 31 Dec 2023,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
181 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,818,611 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, Octagon Capital Advisors LP, AMERIPRISE FINANCIAL INC, Invus Financial Advisors, LLC, Boxer Capital, LLC, DIMENSIONAL FUND ADVISORS LP, and ALLIANCEBERNSTEIN L.P..
This page lists
181
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.